Maze Therapeutics, Inc. Common Stock (MAZE) is a publicly traded Healthcare sector company. As of November 9, 2026, MAZE trades at $34.89 with a market cap of $1.90B and a P/E ratio of -10.91. MAZE moved +1.96% today. Year to date, MAZE is -12.29%; over the trailing twelve months it is +21.97%. Its 52-week range spans $6.71 to $53.65. Analyst consensus is strong buy with an average price target of $61.67. Rallies surfaces MAZE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks MAZE insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $34.89 |
| Market Cap | $1.90B |
| P/E Ratio | -10.91 |
| EPS | $-2.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $53.65 |
| 52-Week Low | $6.71 |
| Volume | 431.65K |
| Avg Volume | 0 |
| Revenue (TTM) | $20.00M |
| Net Income | $-133.59M |
| Gross Margin | 0.00% |
10 analysts cover MAZE: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $61.67.